Quipt Home Medical Corp. (NASDAQ:QIPT) Q4 2022 Earnings Conference Call December 22, 2022 10:00 AM ET
Company Participants
Gregory Crawford - Chairman, President & CEO
Hardik Mehta - CFO
Conference Call Participants
Doug Cooper - Beacon Securities Limited
Rahul Sarugaser - Raymond James
Tania Armstrong-Whitworth - Canaccord Genuity
Christopher Pu - IA Capital Markets
Bill Sutherland - Benchmark Company
Operator
Thank you for standing by. This is the conference operator. Welcome to the Fiscal Fourth Quarter and Unaudited Full Year 2022 Results Conference Call for Quip Home Medical Corp. [Operator Instructions]
We remind you that remarks today will include forward-looking statements that are subject to important risks and uncertainties. For more information on these risks and uncertainties, please see the reader advisory at the bottom of the company's results news release. The company's actual performance could differ materially from these statements.
At this point, I'd like to turn the call over to Chairman and Chief Executive Officer, Greg Crawford.
Gregory Crawford
Thank you, operator, and thank you all for joining us today on the call. My name is Greg Crawford, and I'm the Chairman and Chief Executive Officer of Quipt Home Medical. Joining me today is Hardik Mehta, our Chief Financial Officer.
I want to start by thanking the more than 900 Quipt team members for their ongoing commitment to delivering first-rate patient care in order to enhance the quality of life for each and every patient we serve. We are able to successfully run a patient-centric ecosystem across the entire company by collaborating with our key sales touch points, which include health care providers like hospitals, doctors, rehab centers and long-term care facilities.
Our ability to harness the technology platforms we have established over the past few years, along with our specialized clinical respiratory programs, has made it possible for us to efficiently treat patients at home in a way that best meets their needs with the ability to monitor patients in greater numbers, reduce organizational redundancy and lower overall health care costs.
The high touch service model we employ geared towards enhancing the quality of life for all of our patients is what distinguishes Quipt in the market. As we carried out our strategic growth plan and future vision, fiscal 2022 has been another active and successful year for Quipt, which included 37% year-over-year revenue growth and continued strong margin stability. For us, it goes without saying that offering a full range of end-to-end respiratory solutions is essential to maintaining our success and a significant growth factor in our key markets.